Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 8, pp. 2142-2151
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 16, 2009
- Revision received April 20, 2009
- Accepted May 4, 2009
- Published first August 11, 2009.
Article Versions
- Previous version (August 11, 2009 - 08:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Issan Yee-San Tam1,
- Elaine Lai-Han Leung1,
- Vicky Pui-Chi Tin1,
- Daniel Tsin-Tien Chua2,
- Alan Dart-Loon Sihoe3,
- Lik-Cheung Cheng3,
- Lap-Ping Chung1 and
- Maria Pik Wong1
- Departments of 1Pathology and 2Clinical Oncology, University of Hong Kong, Queen Mary Hospital; and 3Cardiothoracic Surgery Unit, The Grantham Hospital, Hong Kong
- Requests for reprints:
Maria Pik Wong, Department of Pathology (Li Ka Shing Faculty of Medicine), The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong. Phone: 852-2859-4861; Fax: 852-2872-5197. E-mail: mwpik{at}hkucc.hku.hk
I.Y-S. Tam and E.L-H. Leung contributed equally to this work.
August 2009
Volume 8, Issue 8
Volume 8, Issue 8
Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations
Jump to section
Advertisement